TCL Archive FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity. September 29, 2000
TCL Archive Program Project Scores Have Compressed Review Shuld Return To Rank Order; Broder October 2, 1992
TCL Archive House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase June 18, 1993
TCL Archive An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists. May 13, 2005
TCL Archive DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off June 1, 2001